Purple Biotech presents IM1240 preclinical data at EACR conference

June 11, 2026 7:01 AM

Purple Biotech Ltd. (NASDAQ/TASE: PPBT) presented preclinical data for its lead candidate IM1240 at the European Association for Cancer Research ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found